Navigation Links
Onconova Therapeutics Announces Presentation of Clinical and,Non-Clinical Results for Its Lead Compound ON 01910.Na at American,Association of Cancer Research Conference in Los Angeles

LAWRENCEVILLE, N.J.--(BUSINESS WIRE)--Apr 16, 2007 - Onconova Therapeutics, Inc. today announced the presentation of several scientific studies relating to its lead anticancer drug ON 01910.Na at the Annual Meeting of the American Association for Cancer Research (AACR) being held April 14-18, 2007 in Los Angeles, California. During this meeting, on Sunday, April 15th, Dr. E. Premkumar Reddy, the scientific founder of Onconova was honored as the recipient of the 2006-2007 Society of Asian American Scientists in Cancer Research Award for his fundamental contributions to cancer research.

Data presented in oral and poster sessions will focus on pre-clinical and clinical studies with ON 01910.Na, a novel, targeted, small-molecule anti-cancer compound undergoing multiple clinical trials at several major clinical centers in the USA and abroad. ON 01910.Na has shown broad-spectrum anti-tumor activity against both solid tumors and hematological malignancy in pre-clinical studies, and has demonstrated synergistic activity when combined with several classes of conventional chemotherapeutic agents. The Company is planning multiple Phase 2 and combination Phase I clinical trials with leading investigators at major oncology clinical centers in the USA.

The antitumor activity of ON 01910.Na in combination with Eloxatin(R) (Sanofi-Aventis) is demonstrated in a poster presentation entitled, "ON 01910.Na enhances the in vivo cancercidal effects of Oxaliplatin" by J. Jiang, Y. Li, L. Wang, J. Qu, P. Mannam, E. P. Reddy and James F. Holland (Mount Sinai School of Medicine, New York). Employing a nude mouse model system and human liver, hormone refractory prostate, melanoma, pancreatic and colon tumors, single agent activity of ON 01910.Na was shown for all tumor types tested and this effect was enhanced by combining with Oxaliplatin in the liver, prostate and melanoma tumor models. ON 01910.Na was well tolerated in all case
'"/>




Page: 1 2 3

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
3. CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action for Ranexa
4. Fat Kills Cancer: Turning Stem Cells from Fat Tissue into Personalized, Cancer-Targeted Therapeutics
5. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
6. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
7. Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin for Multiple Sclerosis
8. Orexigen Therapeutics to Present Data on Contrave Impact on Visceral Fat and Insulin Resistance at American Diabetes Association 67th Scientific Sessions in Chicago June 23
9. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
10. Trophos Publishes ALS Article in Journal of Pharmacology and Experimental Therapeutics
11. Novelos Therapeutics Announces Encouraging Results in Ongoing Phase 2 Ovarian Cancer Trial at Dana-Farber/Partners Cancer Care
Post Your Comments:
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
(Date:1/15/2014)...  Echo Therapeutics, Inc. (Nasdaq: ECTE ) ("Echo"), ... as a non-invasive, wireless continuous glucose monitoring system, today ... and Interim CEO of Echo Therapeutics, will present at ... Mr. Doman will make a corporate ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3
... Conatus Pharmaceuticals Inc., a privately held, clinical stage ... Hepatitis C Virus (HCV), announced today that Steven J. ... at the Montgomery Healthcare Conference being held in Menlo ... of only 30 companies selected to present to this ...
... Hospital of Arcadia, California, has launched an integrated ... solutions designed to help improve the quality of ... health care information technology subsidiary of Quest Diagnostics ... solution to help Methodist reduce the length of ...
Cached Medicine Technology:Conatus Pharmaceuticals to Present at the Montgomery Healthcare Conference 2Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs 2Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs 3Methodist Hospital Adopts New Technology Solutions to Improve Care for California Patients and Reduce Operating Costs 4
(Date:4/17/2014)... Hospital Pediatrician-in-Chief Jon McCullers, MD, was recently invited ... of Nature Reviews Microbiology , one of ... a world-renowned infectious disease specialist, and chair of ... Tennessee Health Science Center, analyzed the epidemiology and ... 1968 pandemics, as well as more recent 2009 ...
(Date:4/17/2014)... 10 million older Americans suffer from depression, often brought ... new research a project that followed the lives ... found that Internet use among the elderly can ... percent. , "That,s a very strong effect," said Shelia ... studies and media who led the project. "And it ...
(Date:4/17/2014)... BostonResearchers from Boston University School of Medicine (BUSM) ... alcohol consumption in an experimental model. The findings, ... and Alcohol Abuse , may lead to more ... alcohol is one of the leading causes of ... significant negative economic impact by limiting the productivity ...
(Date:4/17/2014)... Cesar A. Arias, M.D., Ph.D., at The University of ... a new superbug that caused a bloodstream infection in ... 17 issue of The New England Journal of ... a class of highly-resistant bacteria known as methicillin-resistant ... cause of hospital and community-associated infections. The superbug has ...
(Date:4/17/2014)... blood flow and alleviates muscle soreness after exercise, ... University of Illinois at Chicago. , The study, ... Archives of Physical Medicine and Rehabilitation , ... people who had not exercised, suggesting that massage ... of physical activity. , Improved circulation and relief ...
Breaking Medicine News(10 mins):Health News:Internet use can help ward off depression among elderly 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:New MRSA superbug emerges in Brazil 2Health News:Massage therapy improves circulation, eases muscle soreness 2
... ... ‘death panel’ claim as the year’s biggest lie. Finalist for biggest lies also include ... ... PolitiFact.com , the Pulitzer Prize-winning fact-checking Web site of the St. Petersburg Times, ...
... WASHINGTON, Dec. 20 Following is the daily "Profile America" feature ... , SUNDAY, DECEMBER 20: FIRST ORGAN TRANSPLANT , ... transplant in the U.S. was performed this week in 1954 in ... from one identical twin to another, who lived just over eight ...
... health care focuses on costs, a new study from North ... to think of health care spending as an investment that ... projections of health care costs and financing may be unduly ... investment in future capital, contributing to a productive workforce, rather ...
... , WASHINGTON, Dec. 19 Official statement ... , "Majority Leader Reid,s amendment to the Senate health care bill ... current federal law and policy. It does not prevent federal ... protect health care providers who choose to exercise their rights of ...
... , Calls on Senator Ben Nelson to Not ... Senate Majority Leader Harry Reid (D-Nev.) released his long awaited ... The new language is being trumpeted as including an opt-out ... bill worse by requiring the state to either cover all ...
... out of reach of little hands , SATURDAY, Dec. 19 ... at least judging by statistics from a single hospital, but ... say they should be on the list of seasonal safety ... children are treated at Children,s Hospital Boston,s emergency department each ...
Cached Medicine News:Health News:PolitiFact Names 'Death Panels' Claim the Lie of the Year 2Health News:U.S. Census Bureau Daily Feature for Dec. 20 2Health News:Study shows health care spending spurs economic growth 2Health News:Americans United for Life Action: 'Senate Health Care Bill Absolutely Fails To Meet Abortion and Life Protections.' 2Health News:Americans United for Life Action: 'Senate Health Care Bill Absolutely Fails To Meet Abortion and Life Protections.' 3Health News:FRC Rejects Phony Abortion 'Compromise' 2
The Optima III 45 cm line of laparoscopic hand instruments is ideal for operative laparoscopic/endoscopic procedures or when a longer instrument is needed....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
Medicine Products: